Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Tania, Fleitas"'
Autor:
Kerdegari, Hamideh, Higgins, Kyle, Veselkov, Dennis, Laponogov, Ivan, Polaka, Inese, Coimbra, Miguel, Pescino, Junior Andrea, Leja, Marcis, Dinis-Ribeiro, Mario, Kanonnikoff, Tania Fleitas, Veselkov, Kirill
The integration of artificial intelligence (AI) in medical diagnostics represents a significant advancement in managing upper gastrointestinal (GI) cancer, a major cause of global cancer mortality. Specifically for gastric cancer (GC), chronic inflam
Externí odkaz:
http://arxiv.org/abs/2406.18249
Autor:
Tessa S. Groen-van Schooten, Micaela Harrasser, Jens Seidel, Emma N. Bos, Tania Fleitas, Monique van Mourik, Roos E. Pouw, Ruben S. A. Goedegebuure, Benthe H. Doeve, Jasper Sanders, Joris Bos, Mark I. van Berge Henegouwen, Victor L. J. L. Thijssen, Nicole C. T. van Grieken, Hanneke W. M. van Laarhoven, Tanja D. de Gruijl, Sarah Derks
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundTumors in the distal esophagus (EAC), gastro-esophageal junction including cardia (GEJAC), and stomach (GAC) develop in close proximity and show strong similarities on a molecular and cellular level. However, recent clinical data showed tha
Externí odkaz:
https://doaj.org/article/7290fb7a97854b94b461883d4c42e038
Autor:
Hamideh Kerdegari, Kyle Higgins, Dennis Veselkov, Ivan Laponogov, Inese Polaka, Miguel Coimbra, Junior Andrea Pescino, Mārcis Leja, Mário Dinis-Ribeiro, Tania Fleitas Kanonnikoff, Kirill Veselkov
Publikováno v:
Diagnostics, Vol 14, Iss 17, p 1912 (2024)
The integration of artificial intelligence (AI) in medical diagnostics represents a significant advancement in managing upper gastrointestinal (GI) cancer, which is a major cause of global cancer mortality. Specifically for gastric cancer (GC), chron
Externí odkaz:
https://doaj.org/article/9aabcfe1f0de46f7980d00b62a894e95
Autor:
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M. Sánchez del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andrés Cervantes, Josefa Castillo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-22 (2023)
Abstract Background Patient-derived organoids (PDOs) from advanced colorectal cancer (CRC) patients could be a key platform to predict drug response and discover new biomarkers. We aimed to integrate PDO drug response with multi-omics characterizatio
Externí odkaz:
https://doaj.org/article/a72cfc5ee59741f4839fb4407bd9b3b0
Autor:
Tessa Suzanne van Schooten, Sarah Derks, Elena Jiménez-Martí, Fatima Carneiro, Ceu Figueiredo, Erika Ruiz, Maria Alsina, Cristina Molero, Marcelo Garrido, Arnoldo Riquelme, Carmelo Caballero, Eva Lezcano, Juan Manuel O’Connor, Federico Esteso, Judith Farrés, José Manuel Mas, Florian Lordick, Jeannette Vogt, Antonella Cardone, Charis Girvalaki, Andrés Cervantes, Tania Fleitas, on behalf of the members of LEGACy consortium
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Gastric Cancer (GC) is the fourth most deadly cancer worldwide. Enhanced understanding of its key epidemiological and molecular drivers is urgently needed to lower the incidence and improve outcomes. Furthermore, tumor biology in
Externí odkaz:
https://doaj.org/article/000f8301cb034a3c9478250288367cff
Autor:
Tania Fleitas, Maria Liz Paciello
Publikováno v:
Revista Paraguaya de Reumatología, Vol 5, Iss 2, Pp 39-42 (2019)
El mundo enfrenta un problema de salud crítico debido al envejecimiento de las sociedades, con estilos de vida poco saludables, desigualdades socioeconómicas y una población mundial en crecimiento. El cáncer se está convirtiendo en uno de los pr
Externí odkaz:
https://doaj.org/article/bd820cccb229404790afc99a2d7ca52f
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
Autor:
Tania Fleitas-Kanonnikoff, Carolina Martinez‐Ciarpaglini, Josefina Ayala, Cinthia Gauna, Rita Denis, Ita Yoffe, Silvia Sforza, María Teresa Martínez, Alicia Pomata, Maider Ibarrola‐Villava, Sipan Arevshatyan, Verónica Burriel, Diego Boscá, Oscar Pastor, Ana Ferrer‐Martinez, Francisca Carrasco, Cristina Mongort, Samuel Navarro, Gloria Ribas, Andres Cervantes
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 3120-3130 (2019)
Abstract Somatic mutation analysis and evaluation of microsatellite instability (MSI) have become mandatory for selecting personalized therapy strategies for advanced colorectal cancer and are not available as routine methods in Paraguay. The aims of
Externí odkaz:
https://doaj.org/article/c4ab06011a3946a985a944f3fdd2eacb
Autor:
Valentina Gambardella, Andrés Cervantes, Elisa Fontana, Katherine Eason, Anguraj Sadanandam, Carolina Martinez-Ciarpaglini, Marisol Huerta, Susana Rosello, Desamparados Roda, Noelia Tarazona, Federica Papaccio, Francisco Gimeno-Valiente, Sheila Zuniga, Alexandre Calon, Juan Antonio Carbonell-Asins, Pilar Rentero-Garrido, Tania Fleitas, David Moro-Valdezate, Gift Nyamundanda, Josefa Castillo, Alejandro Espí
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Colon cancer (CC) is a heterogeneous disease. Novel prognostic factors beyond pathological staging are required to accurately identify patients at higher risk of relapse. Integrating these new biological factors, such as plasma circulating
Externí odkaz:
https://doaj.org/article/1ba9bbd5d5ea42709d18d95be914965b
Autor:
Manuel Cabeza-Segura, Valentina Gambardella, Francisco Gimeno-Valiente, Juan Antonio Carbonell-Asins, Lorena Alarcón-Molero, Arturo González-Vilanova, Sheila Zuñiga-Trejos, Pilar Rentero-Garrido, Rosana Villagrasa, Mireia Gil, Ana Durá, Paula Richart, Noelia Alonso, Marisol Huerta, Susana Roselló, Desamparados Roda, Noelia Tarazona, Carolina Martínez-Ciarpaglini, Josefa Castillo, Andrés Cervantes, Tania Fleitas
Publikováno v:
BRITISH JOURNAL OF CANCER
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Background Advanced gastro-oesophageal cancer (GEA) treatment has been improved by the introduction of immune checkpoint inhibitors (CPIs), yet identifying predictive biomarkers remains a priority, particularly in patients with a combined positive sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c0435ab96eb48406880f88f70a77f6
https://doi.org/10.1038/s41416-022-02005-z
https://doi.org/10.1038/s41416-022-02005-z
Autor:
Enriqueta Felip, Juan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, Alejandro Navarro Mendivil, Maria Martinez Garcia, Alvaro Taus Garcia, Natasha Leighl, Ulrik Lassen, Morten Mau-Soerensen, Celine Adessi, Francesca Michielin, Ian James, Maurizio Ceppi, Max Hasmann, Martin Weisser
Publikováno v:
ESMO Open, Vol 4, Iss 4 (2019)
Purpose This study investigated the safety and clinical activity of lumretuzumab, a humanised antihuman epidermal growth factor receptor 3 (HER3) monoclonal antibody, in combination with carboplatin and paclitaxel in first-line treatment of patients
Externí odkaz:
https://doaj.org/article/2579db173c034d929a05203fd637d4c5